Supernus Pharmaceuticals | Activos Circulantes



Current Assets Cambio Fecha
Abbott USD 23.15B 503M 2025-03
ANI Pharmaceuticals USD 527.68M 6.39M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Eisai JPY 761.1B 79.19B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Indivior 883M 44M 2025-03
Novo Nordisk 195.16B 17.66B 2024-09
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12



Supernus Pharmaceuticals Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.